Invenomic Capital Management’s KBR KBR Stock Holding History

Invenomic Capital Management’s Portfolio KBR Stock Details KBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-19,316	Closed	-$400K	–	172
2020 Q1	$400K	Buy	+19,316	New	+$499K	0.33%	85

Other funds holding KBR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Invenomic Capital Management's KBR Position: Q2 2020 in Review

Invenomic Capital Management sold out of KBR (KBR) in Q2 2020, closing a stake of 19,316 shares — an estimated $400K sold.

Invenomic Capital Management first reported a position in KBR in Q1 2020 and held it in 1 quarter. The position peaked at $400K in Q1 2020. 244 funds tracked by Wall St. Rank hold KBR as of Q2 2020.

Invenomic Capital Management reported no remaining KBR position as of Q2 2020 after selling out during the quarter.
Invenomic Capital Management sold 19,316 KBR shares in Q2 2020, an estimated $400K.
Invenomic Capital Management first reported a position in KBR in Q1 2020 and held it in 1 quarter.
Invenomic Capital Management's KBR position peaked at $400K in Q1 2020.
244 funds tracked by Wall St. Rank held KBR as of Q2 2020.

Based on Invenomic Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.